DTx East 2022
5th Annual

DTx East 2022

September 27-29th | Boston, MA

Catalysing the Digital Evolution of Healthcare

 

 

Agenda Register Now for DTx East 2022

Partners

Knowledge Partners
Knowledge Partner

Biofourmis is a global leader in virtual care and digital therapeutics, offering innovative solutions that enable clinicians to deliver personalized predictive care to patients outside of a traditional hospital, clinic, or clinical research environment.

Learn More

Knowledge Partner

BrightInsight provides the leading global regulated digital health platform for biopharma and medtech. Every line of code of our BrightInsight Platform is built under a Quality Management System to support and optimize regulated drugs, devices and software through integrated data and actionable insights to enable customers to drive increased patient adherence and engagement. The BrightInsight™ Platform uses software and services to capture, transmit and analyze data from CE-marked and FDA-regulated medical devices, combination products, apps and Software as a Medical Device, in compliance with global security, privacy and regulatory requirements. Deployed as a managed service, the platform accelerates time to market for biopharma and medtech companies, reduces the cost of implementation and maintenance versus a custom solution, and scales across products and global markets.

Learn More

Knowledge Partner

Castor is a leading provider of decentralized and hybrid clinical trial solutions to democratize research. With the highest rated eClinical platform for decentralized and hybrid clinical trials, Castor’s plug and play platform offers rapid deployment at scale, enabling researchers to create a trial in a matter of clicks, with easy enrollment, consent and real-world data capture. Castor is bringing human-centered design to the clinical trial process, from recruitment to analysis, and improving the quality, security and reusability of data for researchers worldwide.

Learn More

Knowledge Partners

Curebase is a leading provider of decentralized clinical research software and services for digital therapeutics. Curebase enables any patient and any healthcare provider to be part of a clinical study, accelerating enrollment and enabling novel study designs with diverse populations. Curebase operates as a complete eClinical software platform, virtual research site, and full-service CRO.

Learn More

Knowledge Partner

Decimal.health is a specialized digital health consulting firm that creates and implements
strategies to launch and grow digital health products and services. Through our deep network
and expertise in US healthcare delivery and regulations, we help digital health businesses
navigate the complex DTx and FDA regulatory path and gain traction with investors and
customers

Learn More

Knowledge Partners

We set our sight on a simple, but powerful vision to advance life science services toward a healthier world.

The journey began when Water Street Healthcare Partners and JLL Partners joined forces to acquire and combine the most comprehensive platform of life sciences services in the industry. Together, we are EVERSANA.

We offer more than 500 clients – from start-ups to established global pharmaceutical leaders – the services they need to bring critical therapies to market while improving the lives of patients around the world.

Learn More

Knowledge Partner
Kemtai is an adaptive exercise platform that uses advanced computer vision and AI to analyze human motion and provide real-time guidance and feedback.

Focusing on remote physiotherapy and digital health platforms, Kemtai’s software platform can run on any device and guide users as if a personal therapist was right there with them.
Kemtai provides immediate feedback, corrective guidance and qualitative scoring, creating a hyper-personalised, effective and engaging experience.

 

Learn more

Knowledge Partner
Komodo Health is a technology platform company creating the new standard for real-world data and analytics by pairing the industry’s most complete view of patient encounters with enterprise software and machine learning that connects the dots between individual patient journeys and large-scale health outcomes. Across Life Sciences, payer, provider, and developers, we help our customers unearth patient-centric insights at scale — marrying clinical data with advanced algorithms and AI-powered software solutions to inform decision making, close gaps in care, address disease burden, and help the enterprise create a more cost-effective, value-driven healthcare system.
Knowledge Partners
Knowledge Partner

Ieso is a data-driven AI healthcare company pioneering next-generation digital therapeutics to improve mental health outcomes and access to care. 

The company is developing a pipeline of AI-driven evidence-based mental health assessment tools and solutions to democratize access to mental health therapy at scale. With a network of more than 600 fully qualified therapists, ieso provides virtual care (or telehealth) serving more than 20 million adults through the UK National Health Service (NHS), delivering more than 460,000 hours of cognitive behavioral therapy (CBT).

The company has analyzed over 500 million datapoints to decode the active ingredients of therapy to develop scalable digital therapeutics. ieso’s research has been published in several peer-reviewed journals including the Lancet and JAMA, shaping our understanding of scalable digital mental healthcare solutions.

Learn More

Knowledge Partner

IQVIA is a world leader in using data, technology, advanced analytics, and expertise to help customers drive healthcare forward. Together with the companies we serve, we are enabling a more modern and effective healthcare system and creating breakthrough solutions that transform business and patient outcomes.

Learn More

Knowledge Partner

TopLine Power® is what Simon-Kucher is all about. We help clients grow revenue through optimization of strategy, pricing, marketing, and sales across industries.
We are a thought leader in these topics at the intersection of digitalization and life sciences, positioning our clients thrive in the healthcare industry of the future.

Learn More

Knowledge Partner

SoftServe is a trusted technology advisor and provider. We enable our clients across the healthcare continuum to build transformative patient experiences, gain data insights, and accelerate business outcomes. SoftServe’s experts deliver innovation, quality, and speed built on a foundation of empathetic, human-focused experience design.

Learn More

Knowledge Partner

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive.

Learn More

ZS is a professional services firm that works side by side with companies to help develop and deliver products that drive customer value and company results. We leverage our deep industry expertise, leading-edge analytics, technology and strategy to create solutions that work in the real world. With more than 35 years of experience and 10,000-plus ZSers in more than 25 offices worldwide, we are passionately committed to helping companies and their customers thrive.

Learn More

Summit Partners
Summit Partner

DTxCC: a boutique consultancy focused solely on Digital Therapeutics and Digital Health commercialization

We specialize in go-to-market strategy development:

– Market Access and  Reimbursement
– Business models development
– Data monetization

Our Payer Advisory Council provides actionable insight

Custom qualitative research
– One-one-one interviews

Advisory board meetings
– Virtual
– Live face-to-face meetings

Learn More

Summit Partner

Bold Insight is a UX and human factors research agency based in Chicago. Our projects span the product development life cycle, we conduct user research informing early product design to global human factors validation. We work with digital, next-generation technology—medical devices to mobile apps, IFUs to customer journeys.

Learn More

Summit Partner

Curavit is a “Virtual CRO” that designs and executes decentralized – or “virtual” – clinical trials.  Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality.  Curavit brings together the world’s leading researchers, enrolls previously untapped and underserved patient populations, applies machine learning algorithms to health and social engagement information to recruit participants, and leverages leading telehealth, patient data, and medical device technologies.  Curavit’s central virtual site supports remote monitoring and is always audit ready.

Learn More

Summit Partner

Innovaccer Inc., the Health Cloud company, is dedicated to accelerating innovation in healthcare. The Innovaccer® Health Cloud unifies patient data across systems and care settings, and empowers healthcare organizations to develop scalable, modern applications that improve clinical, financial, and operational outcomes. Innovaccer’s solutions have been deployed across more than 1,600 care settings in the U.S., enabling more than 96,000 providers to transform care delivery and work collaboratively with payers and life sciences companies. Innovaccer has helped its customers unify health records for more than 39 million people and generate over $1B in cumulative cost savings. Innovaccer is the #1 rated Data and Analytics Platform by KLAS, and the #1 rated population health technology platform by Black Book.

Learn More

Supporters
Supporter

At our core is perseverance, a fierce determination to overcome any obstacle regardless of setbacks, on behalf of patients and their loved ones. We place greater value on what we can achieve together than on what we can do alone because the needs of those we serve always come first. We will not be bound by doing what’s been done before. Instead, we free ourselves from preconceived notions to discover solutions that advance patient care. Our mission is clear: Otsuka-people, creating new products for better health worldwide.

Learn More

Supporter

JAZZ Venture Partners invests in companies that extend the boundaries of human performance — improving how we live, learn, work, play, and experience the world.

We seek breakthroughs at the intersection of digital technology and neuroscience that are influencing the human experience, such as augmented reality, artificial intelligence, immersive gaming, and closed-loop human-computer systems.

Our portfolio companies are unlocking human potential in health, mind-body wellness, accelerated learning and training, sports, entertainment, and the enterprise.

Learn More

Supporter
Twill, formally known as Happify Health, is The Intelligent Healing Company™. We shorten the distance between need and care by configuring personalized digital therapeutics and care solutions at scale for the modern healthcare cloud. Our platform integrates AI with empathy, making healing more personal, precise, and connected for the entire care journey. We deploy a full spectrum of clinical-grade care solutions—including Digital Therapeutics, Coaching, Community, and Well-being products—for pharma, health plans, enterprises, and individuals everywhere.
Our global platform is available in 10 languages, supports more than 10 chronic conditions, and covers more than 20 million lives.
Supporters

Voluntis is an Aptar Pharma company and part of AptarGroup, Inc., a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Voluntis creates digital therapeutics that empower people with chronic conditions to self-manage their treatment every day, thus improving real-world outcomes. Voluntis’ solutions combine mobile and web apps, using clinical algorithms to deliver personalized recommendations to patients and their care teams to adjust treatment dosage, manage side effects or monitor symptoms.

Leveraging its Theraxium technology platform, Voluntis designs digital therapeutics solutions across multiple areas, including oncology and diabetes. Based in Cambridge, MA, and Paris, France, Voluntis is a founding member of the Digital Therapeutics Alliance.

Learn More about Voluntis

Learn More about Aptar

About Us

DTx East 2022 is aligned with the digital therapeutics industry and its efforts to establish digital within healthcare.

Dedicated to tackling key challenges around reimbursement, regulation, physician adoption, patient engagement and more, DTx East 2022 is set to empower the experts and catalyze the digital evolution of healthcare.

About Us
DTx East in a Nutshell
East 3 days
Three Full Days of Leading Content

DTx East 2022 is back with a bang! Bringing you 3 full days of cutting-edge content and an industry leading speaker faculty, this event provides you with a one-stop shop of all things digital therapeutics ensuring you leave the event with key takeaways and the knowledge to accelerate your own digital journey. We’ve got a lot to catch up on and DTx East has got you covered!

3 Distanced people
Fully In-Person

The time has come to meet in-person once again! Join your peers for live presentations, engaging discussions and face-to-face networking. Step away from the screen for 3 days of industry-defining discussions and catch up with old and make new connections within the field. With some of the audience tuning in virtually, use our dedicated session to network with industry leaders from across the globe.

DTx East Online Icon
Senior & Multifaceted Community

Experts from every stakeholder within the digital therapeutics space will be descending on Boston in September. Join your peers from leading DTx companies, Pharma, Payers, Providers, Government Bodies, Policy Makers and more!

DTx conferences are excellent places to collaborate with top leaders and stay current on the often complex and evolving trends shaping our investments – all while being part of a passionate, growing community of entrepreneurs.

Elan Tye, Principal, JAZZ Venture Partners

The DTx series is more than a conference – it’s become a community with mutual interest in advancing digital therapeutics.

David Stevenson, Managing Director, Merck Global Health Innovation Fund

The people I have met and the discussions I have had during and between sessions at past in-person DTx events have turned into friendships and business relationships that are the true highlights of the DTx events.. I am really looking forward to being part of the in-person interactions at this year’s DTx East.

Brent Vaughan, CEO, Cognito Therapeutics

DTx West 2021 did not disappoint!  Even though this was a virtual conference the quality of presentations were stellar. Looking forward to DTx East!

Debra Reisenthel, Founding CEO, Freespira
DTx East 2022 Speaker Faculty
Brendon O'Leary
Brendon O'Leary
Acting Director, Digital Health Centre of Excellence
U.S FDA
Brendon O'Leary
Acting Director, Digital Health Centre of Excellence
U.S FDA
Meg Barron
Meg Barron
VP, Digital Health Innovations
American Medical Association
Meg Barron
VP, Digital Health Innovations
American Medical Association

Meg is passionate about driving change by collaborating with physicians, technology leaders and solution innovators to improve health care. She has served in product development and business development leadership roles at the AMA and most recently is responsible for driving the roadmap of initiatives that support the AMA’s digital health and medicine strategy. In addition, she has led partnerships and innovation related initiatives, such as the inaugural AMA Healthier Nation Innovation Challenge, the establishment of the AMA Interaction Studio at MATTER, the AMA Physician Innovation Network that enables entrepreneurs and physicians to collaborate on the development of new solutions, the AMA Digital Health & Telehealth Implementation Playbook series, AMA Digital Health research and The Telehealth Initiative with collaborators. She participates on the Advisory Board for MATTER, MassChallenge HealthTech, HealthTech Arkansas, Together.Health and as a TEDMed Research Scholar. She also participates on the Editorial Review Board of The Telehealth and Medicine Today Journal.

Meg has spoken at national conferences such as Health 2.0, Connected Health, HLTH, American Telemedicine Association National Conference, AMA State Advocacy Conference and contributes as speaking faculty for Columbia Business School’s Digital Health program curriculum. She has articles published in Health Affairs, Harvard Business Review and Nature Digital Medicine.

Prior to AMA, Meg worked in the Consumer Product & Retail vertical at Capgemini and at SmithBucklin Corporation for various business and health care clients.

Joe Powers
Joe Powers
VP & Chief Digital Business Officer
Otsuka Pharmaceutical North America
Joe Powers
VP & Chief Digital Business Officer
Otsuka Pharmaceutical North America
Camille McMullen
Camille McMullen
VP, Government Sales
Freespira
Camille McMullen
VP, Government Sales
Freespira
Kamal Jethwani
Kamal Jethwani
Co-Founder & CEO
Decimal Health
Kamal Jethwani
Co-Founder & CEO
Decimal Health

Kamal is an industry leader with 15+ years of experience in digital health from a provider perspective, most recently at MassGeneral Brigham, with a background in digital health strategy, product design and clinical research and validation. Kamal has developed and implemented 100+ digital health programs and is widely published in the value digital health can bring to healthcare delivery.

Mike Telem
Mike Telem
Co-Founder & CBO
Kemtai
Mike Telem
Co-Founder & CBO
Kemtai
Mike is the Co-founder and Chief Business Officer at Kemtai. He is a serial entrepreneur with experience in building and marketing digital products. Mike was previously VP of Product Innovation and Product Marketing at Marketo which he joined Marketo following the acquisition of Insightera, the startup he co-founded in 2009 which provided a real-time web personalization SaaS for global businesses.
Alyssa Reisner
Alyssa Reisner
Lead Director & Principal
CVS Health Ventures
Alyssa Reisner
Lead Director & Principal
CVS Health Ventures

Alyssa Reisner is a Lead Director and Principal at CVS Health Ventures. In her role, she sources, evaluates, and executes investments in innovative health care companies. She has built strategic relationships and executed investments for CVS Health in areas spanning DTx, women’s health, behavioral health, COVID-19 initiatives, and more.

Everett Crosland
Everett Crosland
Chief Commercial Officer
Cognito Therapeutics
Everett Crosland
Chief Commercial Officer
Cognito Therapeutics
Katie Chowdhury
Katie Chowdhury
Director of Regulatory Affairs
Abbvie
Katie Chowdhury
Director of Regulatory Affairs
Abbvie

Katie joined AbbVie in May 2021 as a Director of Regulatory Affairs for the newly formed Digital &
Medical Device Team in the Emerging Technology & Combination Product group. In this role, Katie and
her team support internally developed SaMD projects providing regulatory strategy during development
and GRL support prior to global launch. In addition, Katie is the lead Device Regulatory for the ABBV-
RGX-314 partnership between AbbVie and Regen X Bio supporting both key ancillary devices required
for the Subretinal and Suprachoroidal delivery of the biologic.
Prior to joining AbbVie, Katie held a biomedical engineer and lead reviewer position the US FDA Center
for Devices and Radiological Health (CDRH) in the Cardiovascular Device Division (DCD) in the Office of
Device Evaluation (ODE) from 2006 until 2015. In this role she was the lead reviewer for interventional
cardiovascular devices including guidewires, guide catheters, bare metal, drug eluting and bioabsorbable
stents. After completing the Leadership Readiness program in 2015, Katie joined the Office of Orphan
Products Development (OOPD) in the Commissioner’s Office where she led review of the Humanitarian
Use Device (HUD) designations, supported the Pediatric Device Consortium and Orphan Clinical Trials
grants. Her last official role at the Agency took her back to CDRH where she headed the partnership with
the Medical Device Innovation Consortium (MDIC) in the External Partnerships sector and supported
regulatory science project development across multiple initiatives including Digital Health, In Vitro
Diagnostics, Early Feasibility Studies (EFS), Case for Quality and Science of Patient Input.
Katie holds her undergraduate degree from the University of Pittsburgh (cum laude) in Biomedical
Engineering (2004) and her master’s degree from Maquette University and the Medical College of
Wisconsin in Healthcare Technology Management (2005). Katie resides in NW Washington DC with her
husband, Atiq, and twin boys, Isaac and Isaiah.

Chris Wasden
Chris Wasden
Chief Strategy Officer
Happify Health
Chris Wasden
Chief Strategy Officer
Happify Health
Beth Keyt
Beth Keyt
VP, Government Affairs
Pear Therapeutics
Beth Keyt
VP, Government Affairs
Pear Therapeutics
Anand Iyer
Anand Iyer
Chief Strategy Officer
Welldoc
Anand Iyer
Chief Strategy Officer
Welldoc

Anand is a respected global digital health leader—most known for his insights on and experience with technology, strategy and regulatory policy. Anand has been instrumental in WellDoc’s success and the development of BlueStar®. Since joining WellDoc in 2008, he has held core leadership positions that included Chief Data Science Officer, President and Chief Operations Officer. He holds an MS and a PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University.

Deepti Jaggi
Deepti Jaggi
Chief Strategy & CommercialOfficer
Better Therapeutics
Deepti Jaggi
Chief Strategy & CommercialOfficer
Better Therapeutics
Chris Barr
Chris Barr
Senior Director
Simon Kucher & Partners
Chris Barr
Senior Director
Simon Kucher & Partners
Anish Shindore
Anish Shindore
Founder & Managing Partner
GSD Health
Anish Shindore
Founder & Managing Partner
GSD Health
Azizi Seixas
Azizi Seixas
Assistant Professor, Departments of Population Health & Psychiatry
NYU Langone
Azizi Seixas
Assistant Professor, Departments of Population Health & Psychiatry
NYU Langone

Dr. Azizi Seixas is a national and international thought leader in precision and
personalized population health, digital health technology and innovation, and novel
analytical tools like AI and machine learning to tackle our most vexing public health
issues. He is currently Associate Professor of Behavioral Health and Psychology at the
University of Miami Miller School of Medicine, Director of The Media and Innovation Lab
(The MIL), Associate Director of the Center for Translational Sleep and Circadian
Sciences (TSCS) and leading the University of Miami’s Digital Therapeutics vertical in the
Institute of Data Science and Computing. He was selected as an Education Champion by
Amazon Web Services for his innovative work using cloud computing technology and his
advocacy for improving education and recognized by Cell Press, the world’s most
renowned scientific publishing house, as top 100 most inspiring Black scientists in
America.
Dr. Seixas’ mission to make healthcare more equitable for all starts with fundamentally
rethinking the paradigms by which data is transformed into stories that inspire action – from how
academic research institutes engage with underserved, disenfranchised and overlooked
communities, to fostering a new generation of scientific leaders from within these communities
to drive future research and innovative thinking.  The University of Miami shares this bold vision,
and recruited Dr. Seixas to establish The MIL as a hot-bed of investigation, innovation, and
collaboration and to integrate more fully with the communities of South Florida and beyond.
Dr. Seixas’ groundbreaking research broadly focuses on three areas: multilevel determinants of
sleep and cardiovascular disease disparities; long-term health consequences of cardiovascular
disease (CVD) disparities; and, developing adaptive, group-tailored, and personalized behavior
modification interventions, with the use of machine learning analytical tools, to improve health
and well-being.
Dr. Seixas is one of the world’s most recognized and renown voices in sleep health, driving
important conversations regarding sleep medicine and emerging technologies, serving as Vice
Chair for the American Academy of Sleep Medicine (AASM) Committee on AI and Machine
Learning and serving as Conference Chair for the AASM Sleep Disruptors Conference. He is a
member of the Philips International Sleep Advisory Board, leading discussions regarding the
matrix between sleep and chronic disease. Dr. Seixas also serves on the Cardiac Rehabilitation
Board of the American Heart Association.

Francesca Wuttke
Francesca Wuttke
Co-Founder & CEO
nen
Francesca Wuttke
Co-Founder & CEO
nen
Bryan Stone
Bryan Stone
SVP, Business Development
Universal Music Group
Bryan Stone
SVP, Business Development
Universal Music Group
Kiran Avancha
Kiran Avancha
Chief innovation Officer
HonourHealth
Kiran Avancha
Chief innovation Officer
HonourHealth
Malinda Peeples
Malinda Peeples
SVP, Clinical Services & Research
Welldoc
Malinda Peeples
SVP, Clinical Services & Research
Welldoc
Kal Patel
Kal Patel
Co-Founder & CEO
BrightInsight
Kal Patel
Co-Founder & CEO
BrightInsight
Whitney Stewart
Whitney Stewart
Director, Clinical Project Management
Curebase
Whitney Stewart
Director, Clinical Project Management
Curebase

Whitney is a Director of Clinical Project Management. She oversees the implementation of multiple
clinical trials at Curebase, including some in digital therapeutics. She has worked in the decentralized
trial space for over 5 years and in clinical research for over 10.

Jay Ahlman
Jay Ahlman
Vice President, CPT Coding and Reimbursement Policy and Strategy
American Medical Association
Jay Ahlman
Vice President, CPT Coding and Reimbursement Policy and Strategy
American Medical Association

Jay Ahlman is Vice President of CPT Coding and Reimbursement Policy and Strategy for the American Medical Association (AMA). Jay joined the AMA in 1999 and has held various roles in healthcare strategy, policy and coding during his tenure.  Since 2008, Jay has led the AMA group responsible for the maintenance of the Current Procedural Terminology (CPT) code set and is the lead staff to the CPT Editorial Panel for the AMA.  During this time Jay has worked with the CPT Editorial Panel to lead many significant changes, including the evolution of CPT Literature Standards and the launch of new CPT coding sections including the Proprietary Laboratory Analyses (PLA) code section.  Jay is also the lead staff to the AMA’s Digital Medicine Payment Advisory Group, which is an advisory body made up of 15 industry experts charged with creating solutions to enable the integration of digital healthcare and telehealth solutions into clinical practice.  Most recently, Jay has been involved in the revision of the CPT Evaluation and Management coding structure and the addition of Remote Physiologic and Remote Therapeutic Monitoring codes to the CPT code set.

Liesl Oldstone
Liesl Oldstone
VP, Health Economics & Market Access
AppliedVR
Liesl Oldstone
VP, Health Economics & Market Access
AppliedVR
Brian Harris
Brian Harris
Co-Founder & CEO
MedRhythms
Brian Harris
Co-Founder & CEO
MedRhythms
Smit Patel
Smit Patel
Strategic Program Lead
Digital Medicine Society (DiMe)
Smit Patel
Strategic Program Lead
Digital Medicine Society (DiMe)

Smit J. Patel, PharmD serves as the Strategic Program Lead at the Digital Medicine Society (DiMe), a 501(c)(3) global non-profit organization dedicated to advancing digital medicine to optimize human health. His work focuses on applied approaches to the safe, effective, ethical, and equitable use of digital technologies to advance its evaluation and implementation in clinical research and care delivery. He is an Advisory Board member for the Brown-Lifespan Center for Digital Health and the Digital Therapeutic Alliance (DTA) and serves on advisory committees for digital health program(s) at the Association of Community Cancer Centers (ACCC), American Pharmacists Association (APhA), and HealthXL. He also serves on the steering committee for the APACMed Digital health reimbursement alliance.

Maria Sullivan
Maria Sullivan
VP, Clinical Development
Pear Therapeutics
Maria Sullivan
VP, Clinical Development
Pear Therapeutics
Andy Molnar
Andy Molnar
Chief Executive Officer
Digital Therapeutics Alliance
Andy Molnar
Chief Executive Officer
Digital Therapeutics Alliance
Nick Dougherty
Nick Dougherty
VP, Digital
Allways Health Partners
Nick Dougherty
VP, Digital
Allways Health Partners
Omar Manajwala
Omar Manajwala
Chief Medical Officer
Dario Health
Omar Manajwala
Chief Medical Officer
Dario Health
Amir Lahav
Amir Lahav
Digital Healthcare Innovation, Head of Digital R&D
Mitsubishi Tanabe Pharma Holding America
Amir Lahav
Digital Healthcare Innovation, Head of Digital R&D
Mitsubishi Tanabe Pharma Holding America

Amir is an established neuroscientist specialized in digital medicine and clinical innovation. His strategic vision is empowered by real-world data that enable the discovery of clinical insights otherwise not possible solely based on conventional health records. Amir has boundless passion for accelerating novel therapies and creating a path for better patient experience. He brings an entrepreneurial zeal to the clinical world through disruptive technology and AI analytics from proof of concepts to scale-up solutions. Prior to pharma , Amir was a professor of Pediatrics and Epidemiology at Harvard Medical School and Harvard School of Public Health and served as a PI on numerous clinical trials with 200+ publications and conference presentations.

Risa Weisberg
Risa Weisberg
Chief Medical Officer
BehaVR
Risa Weisberg
Chief Medical Officer
BehaVR

Dr. Risa Weisberg has devoted her career to developing and scientifically testing scalable interventions for common behavioral health problems. Her mission is to expand the reach of high-quality, science-based behavioral health treatment. She has over two decades of research, clinical, and leadership experience which she now brings to lead the clinical direction and research strategy of BehaVR at Chief Clinical Officer. Risa has a doctoral degree in Clinical Psychology from the University at Albany. She completed a doctoral internship and postdoctoral fellowship at Brown University. She is a Professor of Psychiatry at the Boston University School of Medicine and an Adjunct Professor of Family Medicine at the Alpert Medical School of Brown University. She is an expert in cognitive-behavioral therapy and acceptance and commitment therapies. As a primary care psychologist, Risa has broad experience in treatment development and implementation for common behavioral health problems including anxiety, depression, chronic pain, substance use disorder, and adaptation to living with other chronic medical difficulties. Her research has been funded by the National Institutes of Health, the Patient Centered Outcomes Research Institute, the Veterans Administration, and numerous foundations. Risa is a member of the Scientific Council of the Anxiety and Depression Association of America and a Fellow and former Board Member of the Association for Behavioral and Cognitive Therapies.

Carl Gottlieb
Carl Gottlieb
SVP, Head of Engineering
Akili Interactive
Carl Gottlieb
SVP, Head of Engineering
Akili Interactive
Sarah Schenck
Sarah Schenck
Medical Director, Virtualist Medicine
ChristianaCare Health System
Sarah Schenck
Medical Director, Virtualist Medicine
ChristianaCare Health System
Sean Kinsman
Sean Kinsman
Chief Clinical Officer
Recovery One
Sean Kinsman
Chief Clinical Officer
Recovery One

Sean Kinsman, DPT serves as the Chief Clinical Officer at RecoveryOne, a leading
digital health innovator dedicated to improving health outcomes for recovery from
musculoskeletal (MSK) injuries of all types and reducing costs. Dr. Kinsman has been
instrumental in driving RecoveryOne’s expansion into clinical care and is the
architect behind their network of clinicians who service patients through their digital
treatment pathways. He is a Board Certified Orthopedic Clinical Specialist.
Prior to joining RecoveryOne, Dr. Kinsman contributed to the world-renowned “MICU
Study” while working in clinical practice at Johns Hopkins Hospital. The study focused
on the early mobilization of medically complicated patients in an intensive care unit
setting. Dr. Kinsman was also a key contributor to Johns Hopkins’ Hemophilia Clinic
and Cystic Fibrosis teams, managing long-term complications in both populations.
Dr. Kinsman’s previous experience also includes serving as part of a multi-
disciplinary team of Stanford physicians where he contributed to the creation of an
innovative, intensive recovery program for patients who developed dependence to
prescription opioids. The program averaged a 76% clinical success rate over six
years.
He previously also served as Clinic Director at Henning and Cole, a group of
outpatient therapy clinics in the Baltimore area. He earned his BS, MA and DPT at
Northeastern University, Boston, MA

Jin Lee
Jin Lee
Director of Business Development, Rx+ (Global)
Astellas
Jin Lee
Director of Business Development, Rx+ (Global)
Astellas
Shwen Gwee
Shwen Gwee
VP, Head of Global Digital Strategy
Bristol Myers Squibb
Shwen Gwee
VP, Head of Global Digital Strategy
Bristol Myers Squibb
Steven Driver
Steven Driver
Medical Director, Digital Therapeutics
Advocate Aurora Health
Steven Driver
Medical Director, Digital Therapeutics
Advocate Aurora Health
Ted Burns
Ted Burns
VP, Product
Propeller Health
Ted Burns
VP, Product
Propeller Health

Ted is an experienced media and technology professional with over 25 years of experience in product management and content development. Ted has held various executive, editorial and product management roles at AOL Canada, Yahoo!, and 4INFO where he was Vice President of Products. Starting in 2010 Ted began working as an independent consultant for early-stage companies developing data, online video, and television products and was instrumental in starting RevUp.com, an award-winning company based in Northern California that revolutionized political and non-profit fundraising. Ted is currently working as the Vice President of Product at Propeller Health, one of the top digital health companies in the world that are helping bring connected devices to asthma and COPD patients around the world.

Vandana Menon
Vandana Menon
VP, Clinical Research & Evidence Generation
Akili Interactive
Vandana Menon
VP, Clinical Research & Evidence Generation
Akili Interactive
Derk Arts
Derk Arts
Founder & CEO
Castor
Derk Arts
Founder & CEO
Castor

Derk Arts MD, PhD has over fifteen years of experience in medicine, research and technology. He founded Castor to solve the biggest issues in clinical research: a lack of inclusivity, patient focus and impact of data. Castor enables sponsors worldwide to run patient-centric trials on a unified platform, that helps them maximize the impact of research data on patient lives.

 

Dr. Derk Arts believes the key to achieving lasting change in the industry is through scalability and standardization. Technology to run better trials and maximize the impact of data should be available to all researchers.


Over the past 12 months, Castor provided pro-bono support to over 300 COVID-19 trials, and provided the entire infrastructure for the World Health Organizations’ Solidarity Trials.

Ana Maiques
Ana Maiques
Chief Executive Officer
Neuroelectrics
Ana Maiques
Chief Executive Officer
Neuroelectrics

Ana Maiques is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate the brain to help many patients in need. She was nominated by IESE Business School as one of the most influential entrepreneurs under 40 in Spain in 2010. She received the EU Prize for Women Innovators from the European Commission EC in 2014. In 2015 & 2016, she was named one of the most inspiring women on the Inspiring Fifty list in Europe. Ana continues breaking the barriers of science and technology in an impactful way with Business Ethics.

Jeff Howell
Jeff Howell
Head of Design
Eli Lilly & Company
Jeff Howell
Head of Design
Eli Lilly & Company
Jason Parent
Jason Parent
Director, Clinical Innovation
Point32Health
Jason Parent
Director, Clinical Innovation
Point32Health
Brad Van Orden
Brad Van Orden
Director, Digital Medicine & Digital Therapeutics
Bristol Myers Squibb
Brad Van Orden
Director, Digital Medicine & Digital Therapeutics
Bristol Myers Squibb
Tanya Dillard
Tanya Dillard
VP, Strategy & Innovation
Transcarent
Tanya Dillard
VP, Strategy & Innovation
Transcarent
Adam Kundzewicz
Adam Kundzewicz
Executive Director
Boehringer Ingelheim Venture Fund
Adam Kundzewicz
Executive Director
Boehringer Ingelheim Venture Fund
Sarah Cooper
Sarah Cooper
Product Manager
MedRhythms
Sarah Cooper
Product Manager
MedRhythms
Adriano Garcez
Adriano Garcez
Director, Outcomes Research
ZS Associates
Adriano Garcez
Director, Outcomes Research
ZS Associates
Andy Heusser
Andy Heusser
Senior Data Science Manager
Akili Interactive
Andy Heusser
Senior Data Science Manager
Akili Interactive
Belinda Brummett
Belinda Brummett
Senior Director, Digital Health Engagement, Digital Business
Banner Health
Belinda Brummett
Senior Director, Digital Health Engagement, Digital Business
Banner Health
Dan Rimm
Dan Rimm
Head of Product
Click Therapeutics
Dan Rimm
Head of Product
Click Therapeutics
Michael Malecki
Michael Malecki
Head of Access and Reimbursement
Blue Note Therapeutics
Michael Malecki
Head of Access and Reimbursement
Blue Note Therapeutics
Soňa Sikorová
Soňa Sikorová
Co-Founder & CEO
Mindpax
Soňa Sikorová
Co-Founder & CEO
Mindpax

Soňa is the CEO and co-founder of Mindpax, a company that brings personalized digital care to patients with severe mental illnesses. Mindpax’s DTX for bipolar disorder will be the first product of its kind offered under German DiGA. With a background in finance, Soňa has 7 years of experience with clinical validation of digital health products. She has been cooperating with European and American leading research institutes and opinion leaders. Her ambition is to keep bringing to market meaningful digital solutions that will change mental illness treatment from a guessing game into a data-driven, continuous, targeted care.

Ronny Hashmonay
Ronny Hashmonay
Global Head of Business Transformation
Novartis
Ronny Hashmonay
Global Head of Business Transformation
Novartis
Veera Anantha
Veera Anantha
Co-Founder & CEO
Constant Therapy Health
Veera Anantha
Co-Founder & CEO
Constant Therapy Health

Veera is a hands-on technology executive and business leader with a passion to bring positive change through the power of data and AI. He created Constant Therapy, an award-winning mobile app that uses artificial intelligence to help tens of thousands of people living with neurological conditions regain essential life skills.

Veera also successfully built a number of innovative products at other startups, including at a company acquired by Apple that developed the world’s fastest digital signal processor. He began his career as a Lead Engineer at Motorola developing mobile software and hardware products, and later, as Vice President of Engineering at a startup acquired by Motorola, developed software products that are now used worldwide to manage wireless networks. Veera has six technology patents and recently won TiE Boston’s Entrepreneur of the Year Award. He is an expert mentor at MassChallenge HealthTech and Insight Data Sciences, is a Charter Member of TiE Boston, and is a guest lecturer for Entrepreneurship at Questrom School of Business. Veera holds a PhD in electrical and computer engineering and a Master of Science degree in physics from Northwestern University, as well as a bachelor’s degree from the Indian Institute of Technology in Bombay.

Julia Strandberg
Julia Strandberg
Chief Commercial Officer
Pear Therapeutics
Julia Strandberg
Chief Commercial Officer
Pear Therapeutics
Charles Haddad
Charles Haddad
AVP, Head of Product Strategy, Global Digital Health
Eli Lilly & Company
Charles Haddad
AVP, Head of Product Strategy, Global Digital Health
Eli Lilly & Company
Ariel D. Stern
Ariel D. Stern
Associate Professor, Business Administration | Visiting Professor
Harvard Business School | Hasso-Plattner-Institute's Digital Health Center
Ariel D. Stern
Associate Professor, Business Administration | Visiting Professor
Harvard Business School | Hasso-Plattner-Institute's Digital Health Center
Mark Zhang
Mark Zhang
Associate Chief Medical Officer, Digital Innovation
Brigham & Women’s Hospital
Mark Zhang
Associate Chief Medical Officer, Digital Innovation
Brigham & Women’s Hospital
Jo Masterson
Jo Masterson
Co-Founder & CEO
2morrow
Jo Masterson
Co-Founder & CEO
2morrow
Faisal Al-Husry
Faisal Al-Husry
Principal
Hikma Ventures
Faisal Al-Husry
Principal
Hikma Ventures
Davide Ricci
Davide Ricci
VP, US Software as a Medical Device/Digital Therapeutics
Novo Nordisk
Davide Ricci
VP, US Software as a Medical Device/Digital Therapeutics
Novo Nordisk
Yuri Maricich
Yuri Maricich
Chief Medical Officer
Pear Therapeutics
Yuri Maricich
Chief Medical Officer
Pear Therapeutics
Mike Ravencroft - DTx East 2022
Mike Ravenscroft
Manager
Dreamit Ventures
Mike Ravenscroft
Manager
Dreamit Ventures

Mike Ravenscroft is a Manager with Dreamit Ventures Healthtech. Mike works with the fund’s digital health and medical device startups to accelerate their paths to commercialization and fundraising. He manages a national network of over 100 partners from industry, including leading health systems, insurance carriers, and pharmaceutical companies. Mike previously held investment roles at C5 Capital and CIT GAP Funds. He holds an MBA from the University of Maryland and a BA from the University of Michigan.

Grady Hannah
Grady Hannah
Co-Founder & CEO
Nightware
Grady Hannah
Co-Founder & CEO
Nightware
Santosh Mohan
Santosh Mohan
Vice President, Digital
Moffitt Cancer Center
Santosh Mohan
Vice President, Digital
Moffitt Cancer Center

Partner With Us

The DTx summits are the premier event series for senior executives from DTx companies, Pharma, Investors, HCPs, Payers and more.

DTx East 2022 is the 14th summit in the DTx series. The industry leaders and most exciting newcomers will be in attendance across an in-person and online event. 

The DTx series provides a rare opportunity to showcase your business to a world-class audience. Spaces are limited this year, please contact our commercial manager, Sam (sam@greygreenmedia.com), to discuss your bespoke package.

Contact Us +
Partner With Us

Register for the Event

For pricing and booking options for DTx East 2022 please click the button to go to the registration page.

Registration